Novanta Inc. ($NOVT) 3Q20 Earnings Sneak Peek

Novanta Inc. (NASDAQ:NOVT) manufacturer of medical equipment components, is reporting third quarter earnings results on Tuesday 10th November 2020, before market open.

The consensus estimates from Thomson Reuters are income of $ 0.39 per share.

For the full year, analysts predict revenues of $ 591.07 million, while looking forward to income of $ 1.84 per share.

The Company Outlook

Revenue for 3Q20 are expected in a range of $ 135.00 million ~ $ 142.00 million

Click Here For More Historical Outlooks Of Novanta Inc.

Previous Quarter Performance

Novanta Inc. disclosed income for the second quarter of $ 0.48 per share, from the revenue of $ 144.73 million. Street analysts expected Novanta Inc. to report income of $ 0.23 per share on revenue of $ 138.11 million for the second quarter. The bottom line results beat street analysts by $ 0.25 or 108.70 percent, at the same time, top line results outshined analysts by $ 6.62 million or 4.79 percent.

Stock Performance

Shares of Novanta Inc. traded up $ 1.83 or 1.52 percent on Monday, reaching $ 122.58 with volume of 163.80 thousand shares. Novanta Inc. has traded high as $ 127.66 and has cracked $ 121.76 on the downward trend

According to the previous trading day, closing price of $ 122.58, representing a 81.74 % increase from the 52 week low of $ 66.44 and a 5.41 % decrease over the 52 week high of $ 127.66.

The company has a market capital of $ 4.31 billion and is part of the Technology sector and Scientific & Technical Instruments industry.

Conference Call

Novanta Inc. will be hosting a conference call at 10:00 AM eastern time on 10th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.novanta.com

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The companys Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. Its Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless imaging and operating room integration technologies; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions.

error: Content is protected !!
Exit mobile version